Associating health-related quality-of-life score with time uses to inform productivity measures in cost-effectiveness analysis

B Jiao, A Basu - Pharmacoeconomics, 2023 - Springer
Abstract Background The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis

B Jiao, A Basu - PharmacoEconomics, 2023 - ideas.repec.org
Background The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis

B Jiao, A Basu - PharmacoEconomics, 2023 - econpapers.repec.org
Abstract Background The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.

B Jiao, A Basu - PharmacoEconomics, 2023 - search.ebscohost.com
Abstract Background: The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis

B Jiao, A Basu - PharmacoEconomics, 2023 - pubmed.ncbi.nlm.nih.gov
Background The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.

B Jiao, A Basu - Pharmacoeconomics, 2023 - europepmc.org
Background The Second Panel on Cost Effectiveness in Health and Medicine
recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of …